US · Healthcare

Isracann Biosciences Inc (ISCNF)

Drug Manufacturers - Specialty & Generic

Isracann Biosciences Inc (ISCNF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ISCNF

P/E ratio

18.00

Isracann Biosciences Inc (ISCNF) — FAQ

What is ISCNF's P/E ratio?

The price-to-earnings (P/E) ratio for Isracann Biosciences Inc (ISCNF) is 18.00 (data as of 2026-03-24).

Does Isracann Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Isracann Biosciences Inc (ISCNF). Check the MyAverix Finance app for the latest dividend data.

What sector is Isracann Biosciences Inc in?

Isracann Biosciences Inc (ISCNF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ISCNF listed on?

ISCNF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)